Status: Not yet recruiting
A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
To evaluate the efficacy of arterial infusion chemotherapy and embolization combined with iparplidutol-volerilis (QL1706) as first-line treatment for pancreatic cancer liver metastases based on progression-free survival (PFS).
Participants needed: 38
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Provincial HospitalUpdated: Jan 12, 2026
Eligibility criteria
1. Voluntarily participate in this study, sign the informed consent form, demons... [+9]
**Subjects meeting any of the following criteria will be excluded from this stud... [+32]